BPA Call 36C25921A0001-36C25924N0011

Award Date 10/1/23
Potential Completion Date 9/30/24
Potential Value $142K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Aurora, CO 80045, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Veterans Integrated Service Network 19 (VISN 19), a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc., a for-profit healthcare company that specializes in molecular diagnostic services for cancer. The contract, valued at $90,117.06, is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for MDX Health Testing...
This federal contract award to MdxHealth, Inc. is for $15,964.65 under a Blanket Purchase Agreement (BPA) call against the Veterans Affairs (VA) Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is to provide the VA's Veterans Integrated Service Network (VISN) 17 with MdxHealth's GPS diagnostic testing services, which utilize molecular and genetic biomarkers to assist in the diagnosis and treatment of various cancers affecting veterans. This...
This federal contract award, valued at $151,131.00, was made by the Veterans Integrated Service Network (VISN) 8, a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. The contract is for the provision of prostate cancer testing services, which will be delivered through a Blanket Purchase Agreement (BPA) under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule. Mdxhealth, a multinational healthcare company specializing in cancer...
This federal contract award to Mdxhealth, Inc. is for the provision of Oncotype DX Prostate Testing services to the Veterans Integrated Service Network (VISN) 17, which is part of the U.S. Department of Veterans Affairs (VA). The $319,293.00 Blanket Purchase Agreement (BPA) call contract is made under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and has a period of performance through April 30, 2026. Mdxhealth, a for-profit healthcare company...
This is a federal contract award to Mdxhealth, Inc., a for-profit healthcare company, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract, a Blanket Purchase Agreement (BPA) call under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule, is valued at $430,183.13. The contract is for the provision of proprietary genetic testing services to support patient diagnosis, particularly for cancer, for the VA's Veterans Integrated...
This is a federal contract award to Mdxhealth, Inc., a for-profit healthcare company, for DX Prostate Testing services. The contract, valued at $27,657.57, was awarded by the Veterans Integrated Service Network (VISN) 17, a division of the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) Call order placed under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The award has no set-aside designation and the...
This federal contract award to Mdxhealth, Inc., a for-profit organization, was made by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network (VISN) 8. The $124,259.85 fixed-price delivery order is for the provision of LAB SOFTWARE services under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract. The contract has no set-aside designation and is intended to support quality healthcare for...
This federal contract is for the provision of prostate cancer diagnostic testing services by Mdxhealth, Inc. to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network (VISN) 8. The contract has a period of performance from October 1, 2020 to September 20, 2021, with a completion date of March 31, 2022. It is a firm fixed price delivery order issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule...
This $319,293 firm-fixed-price federal contract was awarded by the Veterans Integrated Service Network (VISN) 17, a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. for the provision of Oncotype DX prostate cancer testing services. The contract was issued as a Blanket Purchase Agreement (BPA) call order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract, which allows the VA to procure these specialized diagnostic testing...
This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Mdxhealth, Inc., a for-profit organization that provides molecular diagnostic services and information to personalize the diagnosis and treatment of cancer. The contract is a Blanket Purchase Agreement (BPA) Call under the VA's existing Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract, with a potential value of $429,495.00. The contract is for proprietary...

This federal contract award to Mdxhealth, Inc. is for providing medical laboratory testing and analysis services to the Veterans Integrated Service Network (VISN) 19 of the U.S. Department of Veterans Affairs (VA). The contract, valued at $141,530.28, is a Blanket Purchase Agreement (BPA) call against the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The services to be provided include cancer diagnostic testing such as Oncotype DX and ConfirmMDx for prostate, lung, and colorectal cancer. This award builds upon Mdxhealth's prior experience delivering specialized cancer testing services to VA healthcare facilities across the country. The contract has a period of performance through September 30, 2024 and does not have a set-aside designation.

Generated 11/8/24, 9:09 AM